Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
about
Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United StatesInstruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedulesCrowdsourcing black market prices for prescription opioids.Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependenceRisk based in vitro performance assessment of extended release abuse deterrent formulationsOral Human Abuse Potential of Oxycodone DETERx® (Xtampza® ER).A critique of Minozzi et al.'s pain relief and dependence systematic review.Abuse-deterrent formulations: part 1 - development of a formulation-based classification system.The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.Systematic review: instruments to assess abdominal pain in irritable bowel syndrome.The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?Opioid abuse-deterrent strategies: role of clinicians in acute pain management.Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure.Opioid system and human emotions.Glial and neuroinflammatory targets for treating substance use disorders.Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone.The ALERRT® instrument: a quantitative measure of the effort required to compromise prescription opioid abuse-deterrent tablets.
P2860
Q28554893-BC1CB716-FE8B-4872-B1DB-3C03A2DAB0E6Q30854873-707ED14D-F7F7-4E70-8739-920622DA1BDCQ33574891-5002EF57-CE9B-4647-99BF-263145B89427Q34106580-F520A077-00F5-4EE0-9E9E-32ACA7890337Q34364912-A87882BE-5008-4772-A4E6-7EC042D5D9F4Q34677759-A6A8DB77-1FBC-4D2C-BB91-FD68A0A195D8Q36209156-A40DCED8-73EF-49FC-9D59-2F479E3FADE7Q36586105-2720FD71-8A16-4867-A277-5CCA14DDEEEFQ37717944-AA9C9622-86CB-433E-B35A-69303DB9F853Q38105373-4D2751C5-95FF-43AF-A8A7-DADDFE30B741Q38265486-0C392D34-F3AA-4C7F-8614-012E7BC8ACEDQ38379235-9D556BEC-1AEC-43C9-8411-E96071F7D33BQ38569948-BA08B928-9B2A-429F-808B-62981F75B580Q38640212-17E983F2-6CC0-4BF8-BD71-FE7D7EE6D774Q38657470-69FD474C-1D4B-434D-953A-89FBB73C1022Q39037700-2242D240-20B1-457B-ADE4-ACC1559B1BC0Q39231627-07FE7D7B-BCE3-44BF-B8E0-C4BA76F3E217Q43076075-7DE15233-9C98-498A-B923-27403713C025Q44344331-D20DBD35-5F30-449D-B08E-ED833AA50162Q44345212-B4B7181C-3C69-4E52-9E1D-A660651455A0
P2860
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Core outcome measures for opio ...... umans: IMMPACT recommendations
@ast
Core outcome measures for opio ...... umans: IMMPACT recommendations
@en
type
label
Core outcome measures for opio ...... umans: IMMPACT recommendations
@ast
Core outcome measures for opio ...... umans: IMMPACT recommendations
@en
prefLabel
Core outcome measures for opio ...... umans: IMMPACT recommendations
@ast
Core outcome measures for opio ...... umans: IMMPACT recommendations
@en
P2093
P2860
P50
P1433
P1476
Core outcome measures for opio ...... umans: IMMPACT recommendations
@en
P2093
Beatrice Setnik
Bob A Rappaport
Charles O'Brien
Chris-Ellyn Johanson
Deborah B Leiderman
Dennis C Turk
Donald R Jasinski
Edgar H Adams
Edward Cone
Ernest A Kopecky
P2860
P304
P356
10.1016/J.PAIN.2012.07.035
P407
P577
2012-09-19T00:00:00Z